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Diasteroselective Synthesis of the A-B-C Tricyclic Ring Structure 
of Stemocurtisine 
 
Xuan Duc Dau[a], Anthony C. Willis[b], Stephen G. Pyne*[a] 
 
Abstract: The diastereoselective synthesis of the A-B-C tricyclic ring 
structure of the Stemona alkaloid stemocurtisine is described. 
Attempts to prepare the C-3a−C-11 ether moiety of this alkaloid 
using a photochemically induced oxidative cyclization method were 
unsuccessful due to cleavage of the A-ring. 
Introduction 
The Stemona alkaloids represent a unique class of natural 
products exclusively isolated from the monocotyledonous family 
Stemonaceae, mainly distributed in East and South East Asia.[1] 
Structurally the alkaloids are characterized by the presence of 
either a pyrrolo[1,2-a]azepine (Figure 1, n = 1), the most 
common type, or a pyrido[1,2-a]azepine core A-B ring structure 
(Figure 1, n = 2).[2] In 2010, Pilli organized the Stemona alkaloids 
into eight different structural groups: stenine, stemoamide, 
tuberostemospironine, stemoamine, parvistemoline, stemofoline 
(all having the pyrrolo[1,2-a]azepine core structure), 
stemocurtisine (having the pyrido[1,2-a]azepine core structure) 
and a miscellaneous group, formed from those alkaloids which 
do not display the structural motifs mentioned above, or are the 
sole representative of a new group.[2]  
 
 
 
 
 
 
Figure 1. Core bicyclic A-B-ring structure of the Stemona alkaloids 
Herbal extracts made from plants belonging to the Stemonaceae 
family have been used in folk medicine in East Asia for 
thousands of years, with three species of the Stemona genus (S. 
tuberosa, S. japonica and S. sessilifolia) being listed in the 2000 
edition of the Chinese Pharmacopoedia as antitussive medicinal  
 
herbs.[3] The dried roots from these species, known as 'Bai Bu' in 
Chinese traditional medicine, 'Bach Bo' in Vietnam and 'Non Tai 
Yak' or 'Pong Mot Ngam' in Thailand, are used to suppress 
coughing, and are claimed to have antituberculosis, antibacterial, 
antifungal and antihelmintic properties.[4] 
 
These interesting biological activities and the synthetically 
challenging polycyclic structures of the Stemona alkaloids have 
prompted numerous synthetic studies and the total synthesis of 
many Stemona alkaloids have been reported.[2a−c, 5] However no 
report has been made on the total synthesis of a stemocurtisine 
group Stemona alkaloid.[6] Here we report on our studies 
towards the total synthesis of stemocurtisine 1 by the 
preparation of the tricyclic compound 3, having the A-B-C ring 
structure of alkaloid 1. Our aim was to employ this compound in 
the synthesis of the tetracyclic compound 2 using a 
photochemical induced oxidative cyclization process to introduce 
the ether bridge between C-3a and C-11 in the target alkaloid. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1. Retrosynthetic analysis of stemocurtisine 2 
 
Our planned synthesis of stemocurtisine 1 was based on the 
retrosynthetic analysis shown in Scheme 1. In principle, this 
alkaloid could be obtained from the tricyclic compound 2 by 
addition of the D-ring, following the method described by Olivo,[7] 
followed by reduction of the lactam carbonyl group.[8] It was 
anticipated that the ether bridge in compound 2 could be 
prepared from the tricyclic compound 3 via a photochemically 
induced oxidative cyclization reaction.[9] The tricyclic compound 
3 could be obtained from the ester 4 via a bromolactonization 
reaction of its corresponding carboxylic acid followed by base-
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catalyzed elimination of HBr and then 1,4-hydride reduction of 
the corresponding -unsaturated lactone. Compound 4 could 
be synthesized from the ene-yne 5 via a RCM reaction after 
reduction of the resulting α,β-unsaturated ester. Related 
chemistry has been developed by Mori for the stereoselective 
synthesis of the pyrrolo[1,2-a]azepine Stemona alkaloid, 
stemoamide[10] and by us for the preparation of 1-
hydroxystemoamide.[11] The ene-yne ester 5 could be obtained 
from ene-yne lactam 6 via functional group interconversions.  
Results and Discussion 
The synthesis of the racemic 5,6-cis-lactam 13 (6, Pg = OTBS) 
started with commercially available 4-pentyne-1-ol which was 
converted to the known Z-iodo ester 8 via the known vinyl iodide 
7 using the literature procedures.[12] A Sonogashira coupling 
reaction of this vinyl iodide with alkyne 9 afforded the novel Z-
ene-yne 10 (J4,5 = 10.7 Hz) in 71% yield which upon epoxidation 
with m-CPBA led to the racemic epoxide 11. The coupling 
constant J4,5 = 4.0 Hz in the 
1H NMR spectrum of 11 was 
consistent with the expected cis-epoxide (Scheme 2).[13] 
 
Aminolysis of epoxide 11[14] with 1-amino-4-pentene (2.0 equiv) 
using LiOTf (1.0 equiv) as a Lewis acid catalyst gave a 
separable mixture of the desired lactam 13, in modest yield 
(26%), and the undesired lactone 12 (13%), lactam 14 (11%), 
and bisadduct 15 (37%) as the major product formed (Scheme 
2). Lactam 14 most likely arises from reaction of 1-amino-4-
pentene with the ester group of 11 followed by an intramolecular 
5-exo-tet cyclization[16] of the resulting amide. An alternative 
mechanism involving the aminolysis of 11 with ring opening at 
C-4 followed by lactam formation seemed less likely since 
aminolysis reactions of vinyl and alkynyl epoxides are normally 
regioselective for attack at the more activated allylic or 
propargylic carbon, as observed in the regioselective ring 
opening of epoxide 19 in Scheme 3. Bisadduct 15 clearly arises 
from the reaction of the lactone 12 with the excess amount of 1-
amino-4-pentene. 
 
In model studies of this aminolysis reaction using epoxide 11 
and allylamine, instead of 1-amino-4-pentene, we found that 
related products were also formed. When less equivalents (1.0 
to 1.2 equiv) of allylamine were used then less amount of the 
bisadduct corresponding to 15 was formed however significant 
amounts of the starting epoxide 11 were also present. Lactone 
12 was converted to lactam 13 in 84% yield by heating a 
solution of 12 in MeOH/Et3N at reflux for 3 d. The vicinal 
coupling constant J5,6 = 4.5 Hz in the 
1H NMR spectrum of 13 
was consistent with the desired 5,6-cis-stereochemistry of the 
lactam 13.[17] However, because of the problem associated with 
the ester group in the ring opening reaction of the epoxide 11 
with amines we developed an alternative synthesis based on the 
epoxide 19 (Scheme 3) in which the problematic ester group 
was replaced with a less reactive CH2OTBS group. 
  
Reaction conditions: (a) I2, MeOH, KOH, rt, 4 h (75%); (b) KOOCN=NCOOK, 
AcOH, pyridine, rt, 10 h (56%); (c) Jones' reagent, acetone, 0 °C, 30 min; (d) 
TMSCl, MeOH, rt, 14 h (60%); (e) 9, CuI, PdCl2(PPh3)2, THF-Et3N, rt, 14 h 
(71%); (f) m-CPBA, CH2Cl2, rt, 18 h (56%). 
Scheme 2. Synthesis of lactam 13. 
The vinyl iodide 7 was transformed to the racemic epoxide 19 
via Sonogashira coupling with the alkene 16, O-TBS protection 
with TBSCl/imidazole, and then epoxidation with m-CPBA 
(Scheme 3). Aminolysis of this epoxide with 1-amino-4-pentene 
in a microwave reactor afforded the amino alcohol 20 in 64% 
yield as a single diastereomer. The relative syn-sterochemistry 
of 20 was consistent with coupling constant J4,5 = 8.5 Hz.
[18] The 
diol 21 was then formed in 91% yield after TBS-deprotection of 
20. Our attempts to oxidize the diol 21 to the corresponding 
lactone using BAIB/TEMPO[19] or NMO/TPAP[20] were 
unsuccessful and resulted in complex mixtures of products. 
However, protection of the amino group of compound 21 as its 
Fmoc-derivative[21] 22 before oxidation with BAIB/TEMPO 
resulted in the lactone 23 in 84% yield. Base promoted Fmoc-
deprotection of 23 with Et3N/MeCN at rt gave the amino lactone 
24 which upon heating with Et3N in MeOH at reflux temperature 
provided the desired 5,6-cis-lactam 25 in 84% yield (Scheme 3). 
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Reaction conditions: (a) 16, CuI, PdCl2(PPh3)3, THF-Et3N, rt, 15 h (79%), (b) 
TBSCl, imidazole, DMF, rt, 8 h (93%); (c) m-CPBA, CH2Cl2, rt, 15 h (63%); 
(d) MW, 1-amino-4-pentene, LiOTf, CH3CN, 120 °C, 60 W, 1.5 h (64%); (e) 
TBAF, THF, 0 °C to rt, 4 h (91%); (f) FmocCl, sat. Na2CO3-THF, 0 °C, 4 h 
(96%); (g) BAIB, TEMPO, CH2Cl2, rt, 16 h (84%); (h) Et3N, CH3CN, rt, 14 h 
(86%); (i) Et3N, MeOH, reflux, 3 d,(84%). 
 
 
Scheme 3. Synthesis of the 5,6-cis-lactam 25 (compounds 19-25 are 
racemic). 
 
For the synthesis of the A-B ring system of stemocurtisine, 
lactam 25 was converted to the ene-yne ester 5 via a sequence 
of functional group interconversions (Scheme 4). This included 
the protection of the secondary alcohol as a TBS ether (TBSOTf, 
2,6-lutidine, 81%),[22] oxidative removal of the PMB group under 
aqueous conditions (DDQ/CH2Cl2/H2O, 79%), oxidation of the 
resulting primary propargyl alcohol to the corresponding acid 
with Jones’ reagent and finally O-methylation (MeI, K2CO3, DMF, 
67% for two steps) to the methyl ester 5. Treatment of 5 with 
Grubbs’ 1st generation Ru catalyst (10% mol, CH2Cl2, rt, 8 h) 
resulted in the bicyclic compound 28 in 78% isolated yield.[10] 
1,4-Hydride reduction of the enoate group of 28 with 
NaBH4/MeOH gave the ester 4 (78%) as a 3:1 mixture of 
diastereomers (Scheme 4).[10]  
Surprisingly, compound 4 was unreactive under our previously 
described dihydroxylation (K2OsO4/NMO)
[11] or Mori’s 
bromolactonization reaction conditions (CuBr2 on alumina on the 
corresponding carboxylic acid).[10] However, treatment of the 
corresponding carboxylic acid of this compound with NBS and 
PhSeSePh[23] in CH3CN led to a mixture of desired product 29 
and its 3a-epimer 30. The minor isomer 30 could be converted 
to 29 by treatment with DBU in CHCl3 (Scheme 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reaction conditions: (a) TBSTf, 2,6-lutidine, CH2Cl2, 0 °C to rt, 14 h (81%); (b) 
DDQ, H2O-CH2Cl2 (1:10), rt, 18 h (79%); (c) Jones' reagent, acetone, 0 °C, 30 
min; (d) K2CO3, MeI, DMF, rt (67%, 2 steps); (e) Grubbs' 1
st Ru catalyst (10% 
mol), CH2Cl2, rt, 8 h (78%); (f) NaBH4/MeOH, 0 °C, 3.5 h (78% dr = 3:1). 
 
Scheme 4. Synthesis of the bicyclic compound 4 
 
  
 
 
 
 
 
 
 
 
 
 
Scheme 5. Synthesis of the tricyclic compound 29 
 
The major product of the bromolactonization of 4 (compound 29) 
and the conversion of compound 30 to compound 29 under 
basic conditions suggest that compound 29 is 
thermodynamically more stable than compound 30. Semi-
empirical calculations (SPARTAN, AM1) on 29 and 30 indicated 
that the heats of formation for compounds 29 and 30 were -
863.2 kJ/mol and -851.5 kJ/mol, respectively, indicating that 29 
was thermodynamically more stable than 30 in the gas phase by 
about 12 kJ/mol. The difference in energy between 29 and 30 
could be attributed to the sterically unfavourable pseudo-1,3-
diaxial interactions between H-3a and H-7β and H-3a and H-11a 
in 30 and the significantly closer calculated distance between 
Me-1' and the oxygen atom of the OTBS group in 30 (2.30 Å) 
compared to that in 29 (2.73 Å). 
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Reaction conditions: (a) Mg, MeOH, 0 °C to rt, 1 d (71%); (b) TBAF, AcOH, 
THF,  0 °C to rt, 16 h (80%). 
 
Scheme 6. Synthesis of the tricyclic lactone 3 
 
Our attempts to reduce the C=C bond of the α,β-unsaturated 
lactone 29 by treatment with NaBH4/NiCl2 or NaBH4/CuCl in 
MeOH were unsuccessful and only unreacted starting material 
was recovered. The less hindered O-TBS deprotected version of 
29 also failed to undergo reduction under these conditions. In 
contrast, the pyrrolo[1,2-a]azepine analogues of these 
compounds were readily reduced under the aforementioned 
conditions.[10,11] However, treatment of 29 with Mg/MeOH[24] 
afforded the saturated derivative 31 as a single isomer in 71% 
yield (Scheme 6). The structure of 31 was confirmed by 2D NMR 
and single crystal X-ray crystallographic analyses. Evidence for 
the configuration of 31 was obtained from NOESY NMR 
experiments (Figure 2). Strong NOESY correlations were 
observed between H-11 and H-11a; H-11a and H-11b; H-11b 
and H-6β; H-11a and H-6β; H-1 and H-3a; and H-1' and H-11, 
H-11a and H-11b (Figure 2). No correlations were observed 
between H3a and H11b or between H1 and H11b, which further 
confirmed the relative configurations at C-1 and C-11b. Finally, 
the relative configuration of 31 was confirmed by its single 
crystal X-ray crystallography structure (Figure 3) which further 
indicated that 31 had the same A-B-C ring relative configuration 
as stemocurtisine 1. Treatment of 31 with TBAF/HOAc in THF 
gave the target compound 3 80% yield (Scheme 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Spartan model (AM1) of 31 with atomic labeling and NOESY 
correlations shown by double-headed arrows 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. ORTEP X-ray crystal structure 31 with atomic labeling 
 
We next planned to prepare the tetracyclic compound 2 
employing a photochemical oxidative cyclization process[9] using 
I2 and PhI(OAc)2. We anticipated that compound 3 would react 
with I2 to form the hypoiodite A, which could then undergo 
homolytic cleavage (in the presence of light) to form the free 
radical B (Scheme 7). The radical B could then be transformed 
to the radical C by intramolecular H-atom abstraction at C-3a. 
The distance between the oxygen at C-11 and H-3a is 2.43 Å in 
the X-ray structure of 31. Thus this oxygen would seem to be 
sufficiently close enough to abstract H-3a to give the resonance 
stabilized radical C. This radical then could then be oxidized to 
the resonance stabilized cation D by PhI(OAc)2. Finally, 
intramolecular attack of the hydroxyl group to the electrophilic 
carbon in D could furnish the desired product 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 7. Anticipated synthesis of the cyclic ether 2 
 
However, irradiation of a CH2Cl2 solution of 3, I2 and PhI(OAc)2 
gave a mixture of products from which the major product was 
isolated as a 2.5:1 mixture of diastereomers (Scheme 8). This 
compound was tentively assigned as the structure 32 and was 
relatively unstable. The 1H NMR spectrum of this compound 
indicated the presence of two isomeric compounds (A: major 
isomer, B: minor isomer) in a ratio of 2.5:1. Both products had 
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an aldehyde resonance (δ 9.81 (s, H4'B); δ 9.79 (s, H4'A)), an 
acetoxy resonance (δ 2.11 (s, CH3COA); δ 2.03 (s, CH3COB)), a 
resonance for a hemiaminal proton (δ 7.06 (d, J = 9.0 Hz, H4B); 
δ 6.66 (d, J = 8.0 Hz, H4A)), and a resonance for a methyl group 
attached to a methine (δ 1.25 (d, J = 6.5 Hz, H1"A); δ 1.21 (d, J 
= 6.5 Hz, H1"B)). The hemiaminal proton H-4 correlated to H-3a 
in the COSY spectrum (observed in both isomers). COSY 
correlations were also observed between H-3 and H-1" and H-3 
and H3a (weak) (Figure 4 (I)). Similarly, the 13C NMR spectrum 
showed resonances for an aldehyde group (δ 200.9 C4'A; 200.6 
C4'B), a hemiaminal carbon (δ 82.6 C4A; 78.2 C4B), a methyl (δ 
21.0, C1'A; 20.8, C1' B) and an acetyl methyl group (δ 15.0 
COMeB; 14.7 COMeA). HMBC correlations were observed 
between H-3 and C-2; H-1“ and C-2; H-4' and C-2' and C-3'; and 
H-4 and the acetoxy carbonyl group (Figure 4 (II)). While the 1H 
and 13C and 2D NMR spectroscopic data were consistent with 
the proposed structure 32 the high resolution mass spectrum 
(HRESIMS calcd. for C15H21O8NNa, (M+Na)
+ 366.1165, found: 
366.1158) indicated a molecular formula of C15H21O8N which 
has two more oxygen atoms than structure 32. Clearly the NMR 
and MS data are not consistent and the structure of the main 
product from this reaction is not conclusive. However it is clear 
that the A-ring of compound 3 had undergone oxidative 
cleavage to a relatively unstable aldehyde product. 
 
 
 
 
 
 
 
 
Scheme 8. Attempted photochemical oxidative cyclization of 3 
 
 
 
 
 
 
 
 
 
Figure 4. Observed COSY correlations (I) and HMBC correlations (II) of 32 
 
A proposed mechanism for the formation of the tentative 
structure 32 is shown in Scheme 9. The hypoiodite A, which 
could from the reaction of 3 with I2, could undergo an ionic-
fragmentation to form the N-acyliminium ion E (Scheme 9, path 
a). Alternatively, the intermediate A could undergo homolytic 
cleavage of the hypoiodite to form the free radical B (Scheme 9, 
path b), which could undergo radical fragmentation to form the 
radical intermediate F. This intermediate could then be oxidized 
to the N-acyliminium ion E by PhI(OAc)2. Addition of acetate to 
this acyliminium ion (from both faces of the iminium ion) would 
provide hemiaminal 32 as a mixture of diastereomers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 9. Proposed mechanism for the formation of 32 
 
Because of the aforementioned fragmentation process, which 
was possibly related to the formation of a N-acyliminium ion, we 
decided to reduce the lactam carbonyl group of 3 to avoid the 
formation of such an intermediate in these reactions. Lactam 31 
was converted to the amine 35 by first following the procedure 
described by Zhang[8] by treatment with Lawesson’s reagent to 
give the thioamide 33 (80% yield) and then reduction to the 
piperidine 34 with Raney-Ni (75%). Finally O-TBS deprotection 
of 34 gave the alcohol 35 (78%). Compound 35 was then 
subjected to the abovementioned photochemical oxidative 
cyclization reaction conditions. Unfortunately, this reaction led to 
a complex mixture of products (Scheme 10) and we were unable 
to isolate any pure product, including the desired product 26, 
due to the small amount of starting material used and the close 
Rf values of the products on TLC. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reaction conditions: (a) Lawesson' reagent, THF, reflux, 3 h (80%); (b) Raney-
Ni, EtOH, reflux, 4 h (75%); (c) TBAF, AcOH, THF,  0 °C to rt, 14 h (78%). 
 
Scheme 10. Synthesis of piperidine 35 and an attempt to make the ether 
compound 36. 
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Conclusions 
In conclusion, a diastereoselective synthesis of the A-B-C tricylic 
ring structure of the Stemona alkaloid stemocurtisine has been 
developed. The tricyclic compound 3 was obtained in 19 steps 
from the known vinyl iodide 7 in an overall yield of 1.2%. 
Attempts to prepare the C-3a−C-11 ether moiety of this alkaloid 
from compound 3 using a photochemically induced oxidative 
cyclization method were unsuccessful due to cleavage of the A-
ring. Alternative procedures to make this ether moiety are now in 
progress. 
Experimental Section 
General Information: All reactions were performed in oven dried 
glassware under an atmosphere of dry nitrogen, unless otherwise stated. 
Anhydrous solvents were purchased or obtained from an anhydrous 
solvent dispenser. 1H and 13C NMR spectra were recorded at 500 MHz 
and 125 MHz, respectively. CDCl3 was used at the NMR solvent unless 
otherwise stated. NMR assignments were based on COSY, HSQC, 
HMBC, NOESY and DEPT experiments. 1H NMR chemical shifts are 
quoted in δ values in ppm and are referenced relative to the chemical 
shift of CDCl3 (7.26 ppm) unless otherwise noted. Coupling constants (J) 
are reported in Hz, with signal multiplicities designated at singlet (s), 
doublet (d), doublet of doublet (dd), doublet of doublet of doublet (ddd), 
triplet (t), quartet (q), doublet of triplets (dt), triplet of doublets (td), 
doublet of doublet of triplets (ddt), multiplet (m), broad singlet (bs), broad 
multiplet (bm), quintet (quin), doublet of quartets (dq). 13C NMR chemical 
shifts are quoted in δ values in ppm and are referenced relative to the 
chemical shift of CDCl3 (77.36 ppm) unless otherwise noted.  Melting 
points are uncorrected. Infrared spectra were obtained as neat samples. 
TLC analyses were performed using aluminium backed silica gel TLC 
plates. Column chromatography was performed using silica gel (40-63 
μm) packed by the slurry method. Known compounds, 7, 8, 9 and 16 were 
prepared according to the literature methods.[12] 
(Z)-Methyl 8-(tert-butyldimethylsilyloxy)oct-4-en-6-ynoate (10): To a 
solution of the vinyl iodide 8 (1.182 g, 4.93 mmol) in Et3N (12 mL) under 
an argon atmosphere were added PdCl2(PPh3)2 (69 mg, 0.098 mmol, 
0.02 equiv) and CuI (189 mg, 0.098 mmol, 0.2 equiv).[12c] The mixture 
was stirred for 15 min then a solution of alkyne 9 (1.005 g, 5.91 mmol, 
1.2 equiv) in THF (6 mL) was added dropwise over a period of 30 min. 
After being stirred for 16 h, the mixture was diluted with Et2O (150 mL) 
and washed with saturated NH4Cl solution (2 x 30 mL). The organic layer 
was dried over Na2SO4 and filtered. The solvent was evaporated in 
vacuo and the residue was purified by column chromatography (1:9, 
EtOAc/petroleum spirit) to give the ene-yne 10 (874 mg, 70% yield) as a 
colourless oil. Rf = 0.62 (1:4, EtOAc/petroleum spirit). IR (neat, νmax/cm
-1): 
2956, 1710, 1168, 1022, 919. 1H NMR (500 MHz, CDCl3) δ = 5.90 (dt, J 
= 10.7, 7.3 Hz, 1H, H4), 5.53 (d, J = 10.7 Hz, 1H, H5), 4.46 (s, 2H, H8), 
3.68 (s, 3H, MeO), 2.61 (dd, J = 14.8, 7.4 Hz, 2H, H3), 2.42 (t, J = 7.5 Hz, 
2H, H2), 0.91 (s, 9H, (CH3)3C), 0.13 (s, 6H, CH3Si) ppm. 
13C NMR (125 
MHz, CDCl3) δ = 173.6 (C1), 141.6 (C4), 110.6 (C5), 93.2 (C6), 81.4 (C7), 
52.6 (C8), 52.0 (MeO), 33.6 (C3), 26.2 (C2), 25.9 ((CH3)3C), 
18.7((CH3)3C), -4.8 (CH3Si) ppm. ESIMS m/z 305 [(M+Na)
+ 100%]. 
HRESIMS calcd. for C15H26O3SiNa: (M+H)
+ 305.1563; found: 305.1544. 
Methyl 3-((2R*,3S*)-3-(3-(tert-butyldimethylsilyloxy)prop-1-
ynyl)oxiran-2-yl)propanoate (11): m-Chloroperbenzoic acid (743 mg, 
4.2 mmol, 1.4 equiv) was added to a solution of the alkene 10 (846 mg, 3 
mmol) in CH2Cl2 (30 mL) and the mixture was stirred at rt for 14 h. The 
reaction was quenched with saturated NaHCO3 solution (50 mL) and the 
aqueous phase was extracted with Et2O (3 x 75 mL). The organic 
extracts were combined, dried over MgSO4 and filtered. The solvent was 
removed in vacuo and the residue was purified by column 
chromatography (1:8, EtOAc/petroleum spirit) to give the epoxide 11 (439 
mg, 56% yield) as a colourless oil and the starting alkene (200 mg, 27%). 
Rf = 0.58 (1:4, EtOAc/petroleum spirit). IR (neat, νmax/cm
-1): 2955, 2239, 
1767, 1251, 1185, 1041. 1H NMR (500 MHz, CDCl3) δ = 4.34 (s, 2H, H8), 
3.70 (s, 3H, MeO), 3.48 (d, J = 4.0 Hz, 1H, H5), 3.14 (ddd, J = 6.6, 5.5, 
4.0 Hz, 1H, H4), 2.53 (t, J = 7.4 Hz, 2H, H2), 2.11 – 1.92 (m, 2H, H3), 
0.90 (s, 9H, (CH3)3C), 0.11 (s, 6H, (CH3)2Si) ppm.
 13C NMR (125 MHz, 
CDCl3) δ = 173.4 (C1), 85.0 (C7), 79.5 (C6), 57.2 (C4), 52.1 (MeO), 52.0 
(C8), 45.7 (C5), 30.7 (C2), 26.1 ((CH3)3C), 25.3 (C3), 18.6 ((CH3)3C), -4.9 
(CH3Si) ppm. ESIMS m/z 321 [(M+Na)
+ 100%]. HRESIMS calcd. for 
C15H26O4SiNa: (M+Na)
+ 321.1498; found 321.1488. 
Aminolysis of epoxide 11 with pent-4-en-1-amine:  Lithium triflate (162 
mg, 1 mmol) and 4-penten-1-amine[15b] (170 mg, 2 mmol) were added to 
a solution of epoxide 11 (298 mg, 1 mmol) in CH3CN (2 mL) in a 
microwave reaction vial. The mixture was heated in a microwave reactor 
at 110 ºC, 200 W for 1 h. The solvent was evaporated in vacuo and the 
residue was purified by column chromatography (1:3 to 100:0, 
EtOAc/petroleum spirit). Four compounds 12-15 were obtained.  
(R*)-5-((R*)-4-(tert-Butyldimethylsilyloxy)-1-(pent-4-enylamino)but-2-
ynyl)dihydrofuran-2(3H)-one (12): Colourless oil, 46 mg, 13% yield. Rf 
= 0.58 (1:4, EtOAc/petroleum spirit). IR (neat, νmax/cm
-1): 3330, 2929, 
1765, 1657, 1461, 1253, 1080, 814, 777. 1H NMR (500 MHz, CDCl3) δ = 
5.78 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, H4''), 5.00 (d, J = 17.0 Hz, 1H, H5''), 
4.94 (d, J = 10.0 Hz, 1H, H5''), 4.54 (dd, J = 12.5, 4.5 Hz, 1H, H5), 4.31 
(s, 2H, H4'), 3.53 (d, J = 4.5 Hz, 1H, H1'), 2.88 (dt, J = 11.5, 7.0 Hz, 1H, 
H1''), 2.65 – 2.55 (m, 2H, H1'' and H3), 2.51 (dt, J = 18.0, 9.0 Hz, 1H, H3), 
2.36 – 2.27 (m, 1H, H4), 2.24 – 2.14 (m, 1H, H4), 2.09 (q, J = 7.0 Hz, 2H, 
H3''), 1.59 – 1.53 (m, 2H, H2''), 0.89 (s, 9H, (CH3)3C), 0.10 (s, 6H, 
(CH3)2Si) ppm. 
13C NMR (125 MHz, CDCl3) δ = 177.1 (C2), 138.5 (C4''), 
115.1 (C5''), 84.3 (C2'), 81.9 (C3'), 81.5 (C5), 54.7 (C1'), 52.0 (C4'), 47.5 
(C1''), 31.7 (C3''), 29.4 (C2''), 28.7 (C3), 26.1 ((CH3)3C), 24.6 (C4), 18.6 
((CH3)3C), -4.8 (CH3Si) ppm. ESIMS m/z 374 [(M+Na)
+ 100%]. HRESIMS 
calcd. for C19H33O3NNaSi (M+H)
+ 374.3127; found: 374.3137. 
(5R*,6R*)-6-(3-(tert-Butyldimethylsilyloxy)prop-1-ynyl)-5-hydroxy-1-
(pent-4-enyl)piperidin-2-one (13): Colourless oil, 92 mg, 26% yield. Rf 
= 0.58 (1:4, EtOAc/petroleum spirit). IR (neat, νmax/cm
-1): 3250, 2928, 
2857, 2310, 1635, 1471, 1251, 834. 1H NMR (500 MHz, CDCl3) δ = 5.79 
(ddt, J = 17.0, 10.0, 6.5 Hz, 1H, H4''), 5.02 (d, J = 17.0, 1H, H5''), 4.96 (d, 
J = 10.0 Hz, 1H, H5''), 4.35 (s, 2H, H3'), 4.32 (d, J = 4.5 Hz, 1H, H6), 
3.99 (dt, J = 10.0, 4.5 Hz, 1H, H5), 3.77 (dt, J = 14.0, 8.0 Hz, 1H, H1''), 
3.13 – 3.06 (m, 1H, H1''), 2.56 (ddd, J = 18.0, 6.5, 4.0 Hz, 1H, H3), 2.43 – 
2.34 (ddd, J = 18.0, 10.0, 7.5 Hz, 1H, H3), 2.12 – 2.04 (m, 3H, H3'' and 
H4), 1.97 – 1.90 (m, 1H, H4), 1.70 – 1.62 (m, 2H, H2''), 0.89 (s, 9H, 
(CH3)3C), 0.10 (s, 6H, (CH3)2Si) ppm. 
13C NMR (125 MHz, CDCl3) δ = 
168.9 (C2), 138.1 (C4''), 115.6 (C5''), 86.1 (C3'), 80.0 (C2'), 66.9 (C5), 
55.2 (C6), 51.9 (C3'), 46.1 (C1''), 31.4 (C3''), 29.6 (C3), 27.1 (C4), 26.8 
(C2''), 26.1 ((CH3)3C), 18.6 ((CH3)3C), -4.9 (CH3Si) ppm. ESIMS m/z 374 
[(M+Na)+ 100%]. HRESIMS calcd. for C19H33O3NNaSi: (M+H)
+ 374.3127; 
found: 374.3127. 
(S*)-5-((S*)-4-(tert-Butyldimethylsilyloxy)-1-hydroxybut-2-ynyl)-1-
(pent-4-enyl)pyrrolidin-2-one (14): Colourless oil, 39 mg, 11% yield. Rf 
= 0.58 (1:4, EtOAc/petroleum spirit). IR (neat, νmax/cm
-1): 3317, 2926, 
1668, 1458, 1252, 1080, 1006, 998, 777. 1H NMR (500 MHz, CDCl3) δ = 
5.80 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, H4''), 5.02 (d, J = 17.0 Hz, 1H, H5''), 
4.97 (d, J = 10.0 Hz, 1H, H5''), 4.56 (d, J = 3.0 Hz, 1H, H1'), 4.31 (s, 2H, 
H4'), 3.80 – 3.64 (m, 1H, H5), 3.66 (ddd, J = 14.0, 9.0, 8.0 Hz, 1H, H1''), 
3.15 (ddd, J = 14.0, 9.0, 5.5 Hz, 1H, H1''), 2.57 – 2.48 (m, 1H, H3), 2.34 – 
2.25 (m, 1H, H3), 2.18 – 2.00 (m, 4H, H2'' and H3''), 1.75 – 1.69 (m, H4), 
1.64 – 1.60 (m, 1H, H4), 0.90 (s, 9H, (CH3)3C), 0.10 (s, 6H, (CH3)2Si) 
ppm. 13C NMR (125 MHz, CDCl3) δ = 176.1 (C2), 138.0 (C4''), 115.5 
(C5''), 86.0 (C3'), 82.6 (C2'), 64.6 (C1'), 61.7 (C5), 51.9 (C4'), 41.8 (C1''), 
31.4 (C3''), 30.5 (C3), 26.9 (C4), 26.1 ((CH3)3C), 21.2 (C2''), 18.6 
((CH3)3C), -4.9 (CH3Si) ppm. ESIMS m/z 374 [(M+Na)
+ 100%]. HRESIMS 
calcd. for C19H33O3NNaSi: (M+H)
+ 374.3127; found: 374.3115. 
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(4R*,5R*)-8-(tert-Butyldimethylsilyloxy)-4-hydroxy-N-(pent-4-enyl)-5-
(pent-4-enylamino)oct-6-ynamide (15): Yellow solid, 161 mg, 37% yield. 
Mp = 79-81 ºC. Rf = 0.58 (1:4, EtOAc/Petroleum spirit). IR (neat, νmax/cm
-
1): 3401, 2952, 2931, 1460, 1562, 1249, 1168, 1030, 835. 1H NMR (500 
MHz, CDCl3) δ = 6.63 (bs, 1H, NH amide), 5.82 – 5.72 (m, 2H, H4' and 
H4''), 5.00 (d, J = 17.0 Hz, 2H, H5' and H5''), 4.95 (d, J = 10.0 Hz, 2H, 
H5' and H5''), 4.31 (s, 2H, H8), 3.58 – 3.53 (m, 1H, H4), 3.25 (d, J = 9.0 
Hz, 1H, H5), 3.20 (dd, J = 13.0, 6.5 Hz, 2H, H1'), 2.91 – 2.84 (m, 1H, 
H1''), 2.64 – 2.56 (m, 1H, H1''), 2.46 – 2.35 (m, 2H, H2), 2.14 – 2.02 (m, 
5H, H3', H3'' and H3), 1.75 (td, J = 14.5, 7.0 Hz, 1H, H3), 1.66 – 1.54 (m 
4H, H2' and H2''), 0.89 (s, 9H, (CH3)3C), 0.09 (s, 6H, (CH3)2Si) ppm. 
13C 
NMR (125 MHz, CDCl3) δ = 174.8 (C1), 138.2 (C4'), 138.0 (C4''), 115.4 
(C5'),115.3 (C5''), 85.4 (C7), 81.9 (C6), 73.3 (C4), 55.8 (C5), 52.0 (C8), 
46.9 (C1'), 39.7 (C1''), 32.9 (C2), 31.6 (C3'), 31.3 (C3''), 29.3 (C3), 28.7 
(C2'), 28.6 (C2''), 26.1 ((CH3)3C), 18.6 ((CH3)3C), -4.9 (C-Si) ppm. ESIMS 
m/z 437 [(M+H)+ 100%]. HRESIMS calcd. for C24H45O3 N2Si: (M+H)
+ 
437.3183; found: 437.3199. 
Preparation of lactam 13 from the amino-lactone 12: To solution of 
the amino-lactone 12 (43 mg, 0.13 mmol) in MeOH (1.5 mL) was added 
Et3N (337 μL, 25% volume in MeOH) and the mixture was stirred at reflux 
temperature for 3 d. The solvent was evaporated in vacuo and the 
residue was purified by column chromatography (9:1, EtOAc/petroleum 
spirit) to afford the lactam 13 (41 mg, 96% yield) as a pale yellow oil.  
(Z)-8-(4-Methoxybenzyloxy)oct-4-en-6-yn-1-ol (17): To a solution of 
the vinyl iodide 7 (1.484 g, 7 mmol) in Et3N (50 mL), were added 
PdCl2(PPh3)2 (112 mg, 0.154 mmol, 0.02 equiv) and CuI (267 mg, 1.54 
mmol, 0.2 equiv) under a nitrogen atmosphere. The mixture was stirred 
for 15 min then a solution of alkyne 16 (1.48 g, 8.4 mmol) in THF (25 mL) 
was added dropwise over period of 30 min. After being stirred for 14 h, 
the mixture was diluted with Et2O (150 mL) and washed with saturated 
NH4Cl solution (2x 50 mL). The organic layer was dried over Na2SO4 and 
filtered. The solvent was evaporated in vacuo and the residue was 
purified by column chromatography (3:7, EtOAc/petroleum spirit) to give 
the ene-yne 17 (1.438 g, 79% yield) as a colourless oil. Rf = 0.61 (1:1, 
EtOAc/petroleum spirit). IR (neat, νmax/cm
-1): 3412, 2937, 1713, 1608, 
1512, 1246, 1173, 1029, 818. 1H NMR (500 MHz, CDCl3) δ = 7.30 (d, J = 
8.5 Hz, 2H, ArH), 6.90 (d, J = 8.5 Hz, 2H, ArH), 5.97 (dt, J = 10.5, 7.5 Hz, 
1H, H4), 5.57 (d, J = 10.5 Hz, 1H, H5), 4.56 (s, 2H, OCH2Ar), 4.30 (s, 2H, 
H8), 3.82 (s, 3H, OMe), 3.67 (t, J = 6.5 Hz, 2H, H1), 2.44 (q, J = 7.5 Hz, 
2H, H3), 1.73 – 1.67 (m, 2H, H2) ppm. 13C NMR (125 MHz, CDCl3) δ = 
159.7 (ArC), 143.9 (C4), 130.1 (ArCH), 129.8 (ArC), 114.2 (ArCH), 109.7 
(C5), 90.0 (C7), 83.4 (C6), 71.5 (OCH2Ar), 62.4 (C1), 57.9 (C8), 55.6 
(OMe), 31.9 (C2), 26.9 (C3) ppm. ESIMS m/z 283 [(M+Na)+ 100%]. 
HRESIMS calcd. for C16H20O3Na: (M+Na)
+ 283.1316; found 283.1316. 
(Z)-tert-Butyl(8-(4-methoxybenzyloxy)oct-4-en-6-
ynyloxy)dimethylsilane (18): Imidazole (2.176 g, 32 mmol) and TBSCl 
(2.215 g, 14.72 mmol) were added to a solution of alcohol 17 (3.33 g, 
12.8 mmol) in DMF (40 mL) at rt under a N2 atmosphere and the mixture 
was stirred at rt for 6 h. The mixture was then poured into a beaker 
containing water (70 mL) and then extracted with EtOAc (3 x 100 mL). 
The organic extracts were combined, washed with water (2 x 100 mL), 
dried over MgSO4 and filtered. The solvent was evaporated in vacuo and 
the residue was purified by column chromatography (1:9, 
EtOAc/petroleum spirit) to give the TBS ether 18 (4.453 g, 93% yield) as 
a colourless oil. Rf = 0.61 (1:3, EtOAc/petroleum spirit). IR (neat, νmax/cm
-
1): 2931, 2856, 1512, 1426, 1248, 1107, 819, 741. 1H NMR (500 MHz, 
CDCl3) δ = 7.29 (d, J = 8.5 Hz, 2H, ArH), 6.88 (d, J = 8.6 Hz, 2H, ArH), 
5.96 (dt, J = 10.7, 7.4 Hz, 1H, H4), 5.52 (d, J = 10.7 Hz, 1H, H5), 4.55 (s, 
2H, OCH2Ar), 4.29 (s, 2H, H8), 3.80 (s, 3H, OMe), 3.64 (t, J = 6.5 Hz, 2H, 
H1), 2.38 (q, J = 7.3 Hz, 2H, H3), 1.68 – 1.61 (m, 2H, H4), 0.89 (s, 9H, 
(CH3)3C), 0.05 (s, 6H, (CH3)2Si) ppm.
 13C NMR (125 MHz, CDCl3) δ = 
159.7 (ArC), 144.4 (C4), 130.1 (ArCH), 130.0 (ArC), 114.2 (ArCH), 109.1 
(C5), 89.8 (C7) , 83.5 (C6), 71.4 (OCH2Ar), 63.0 (C1), 57.9 (C8), 55.6 
(OMe), 32.4 (C2), 27.2 (C3), 26.3 ((CH3)3C), 18.7 ((CH3)3C), -4.9 (CH3Si) 
ppm. ESIMS m/z 397 [(M+Na)+]. HRESIMS calcd. for C22H34O3SiNa: 
(M+Na)+ 397.2175; found: 397.2156. 
tert-Butyl(3-((2R*,3S*)-3-(3-(4-methoxybenzyloxy)prop-1-ynyl)oxiran-
2-yl)propoxy)dimethylsilane (19): Purified m-chloroperbenzoic acid 
(2.38 g, 13.8 mmol) was added to solution of the alkene 18 (4.3 g, 11.5 
mmol) in CH2Cl2 (150 mL) and the mixture was stirred at rt for 14 h. The 
reaction was quenched with saturated NaHCO3 solution (100 mL) and 
the aqueous phase was extracted with Et2O (3 x 150 mL). The organic 
extracts were combined, dried over MgSO4 and filtered through a short 
column loaded with Al2O3. The solvent was removed in vacuo and the 
residue was purified by column chromatography (1:8, EtOAc/petroleum 
spirit) to give the epoxide 19 (2.825 g, 63% yield) as a colourless oil and 
the starting alkene 18 (0.989 g, 23%). Rf = 0.59 (1:3, EtOAc/petroleum 
spirit). IR (neat, νmax/cm
-1): 3312, 2930, 2856, 1612, 1513, 1465, 1248, 
1094, 834, 755. 1H NMR (500 MHz, CDCl3) δ = 7.27 (d, J = 8.0 Hz, 2H, 
ArH), 6.88 (d, J = 8.0 Hz, 2H, ArH), 4.52 (s, 2H, OCH2Ar), 4.17 (s, 2H, 
H8), 3.80 (s, 3H, OMe), 3.72 – 3.64 (m, 2H, H1), 3.49 (d, J = 3.5 Hz, 1H, 
H5), 3.10 (dd, J = 7.0, 3.5 Hz, 1H, H4), 1.80-1.71 (m, 4H, H2 and H3), 
0.89 (s, 9H, (CH3)3C), 0.05 (s, 6H, (CH3)2Si) ppm. 
13C NMR (125 MHz, 
CDCl3) δ = 159.8 (ArC), 130.1 (ArCH), 129.6 (ArC), 114.2 (ArCH), 82.0 
(C6), 81.8 (C7), 71.6 (OCH2Ar), 63.0 (C1), 58.3 (C4), 57.3 (C8), 55.6 
(OMe), 45.5 (C5), 29.5 (C3), 26.6 (C2), 26.3 ((CH3)3C), 18.6 ((CH3)3C), -
5.0 (CH3Si) ppm. ESIMS m/z 413 [(M+Na)
+ 100%]. HRESIMS calcd. for 
C22H34O4SiNa: (M+Na)
+ 413.2124; found: 413.2126. 
(4R*,5R*)-1-(tert-Butyldimethylsilyloxy)-8-(4-methoxybenzyloxy)-5-
(pent-4-enylamino)oct-6-yn-4-ol (20): Lithium triflate (162 mg, 1 mmol) 
and 4-penteneamine (340 mg, 3 mmol) were added to solution of the 
epoxide 19 (390 mg, 1 mmol) in CH3CN (2 mL) in a microwave reactor 
vial. The mixture was heated in a microwave reactor at 110 ºC, 200 W for 
1.5 h. The solvent was evaporated in vacuo and the residue was purified 
by column chromatography (3:7, EtOAc/petroleum spirit) to give the 
amine 20 (352 mg, 74% yield) as a pale yellow oil. Rf = 0.60 (1:1, 
EtOAc/petroleum spirit). IR (neat, νmax/cm
-1): 3370, 2930, 2855, 1513, 
1465, 1248, 1091, 833, 755. 1H NMR (500 MHz, CDCl3) δ = 7.29 (d, J = 
8.0 Hz, 2H, ArH), 6.90 (d, J = 8.0 Hz, 2H, ArH), 5.83 (ddt, J = 17.0, 10.0, 
6.5 Hz, 1H, H4'), 5.05 (d, J = 17.0 Hz, 1H, H5'), 4.98 (d, J = 10.0 Hz, 1H, 
H5'), 4.53 (s, 2H, OCH2Ar), 4.18 (s, 2H, H8), 3.83 (s, 3H, OMe), 3.69 (t, J 
= 6.0 Hz, 2H, H1), 3.46 (dd, J = 8.5, 6.0 Hz, 1H, H4), 3.17 (d, J = 8.5 Hz, 
1H, H5), 2.91 (dt, J = 11.5, 7.0 Hz, 1H, H1'), 2.64 (dt, J = 11.5, 7.0 Hz, 
1H, H1'), 2.15 (q, J = 7.0 Hz, 2H, H3'), 1.97 – 1.88 (m, 1H, H3), 1.83-1.74 
(m, 1H, H2), 1.73 – 1.67 (m, 1H, H2), 1.66-1.57 (m, 2H, H2'), 1.54 – 1.45 
(m, 1H, H3), 0.91 (s, 9H, (CH3)3C), 0.07 (s, 6H, (CH3)2Si) ppm. 
13C NMR 
(125 MHz, CDCl3) δ = 159.8 (ArC), 138.6 (C4'), 130.1 (ArCH), 129.8 
(ArC), 115.2 (C5'), 114.2 (ArCH), 85.7 (C6), 81.3 (C7), 73.2 (C4), 71.6 
(OCH2Ar), 63.6 (C1), 57.5 (C8), 56.3 (C5), 55.6 (OMe), 47.0 (C1'), 31.8 
(C3'), 30.7 (C3), 29.6 (C2), 29.3 (C2'), 26.3 ((CH3)C), 18.7 ((CH3)3C), -4.9 
(CH3Si) ppm. ESIMS m/z 476 [(M+H)
+ 100%]. HRESIMS calcd. for 
C27H46O4NSi: (M+H)
+ 476.3196; found: 476.3198. 
(4R*,5R*)-8-(4-Methoxybenzyloxy)-5-(pent-4-enylamino)oct-6-yne-
1,4-diol (21): 1M tetrabutylamonium fluoride solution in THF (3.8 mL, 3.8 
mmol) was added dropwise to a solution of the TBS ether 20 (1.19 g, 2.5 
mmol) in THF (30 mL) at 0 0C and the mixture was warmed to rt and 
stirred for 4 h. Saturated NaHCO3 (50 mL) was added and the aqueous 
phase was extracted with EtOAc (3 x 100 mL). The organic extracts were 
combined, dried over MgSO4 and filtered. The solvent was removed in 
vacuo and the residue was purified by column chromatography (9:1 to 
100:0, EtOAc/petroleum spirit) to give the diol 21 (890 mg, 91% yield) as 
a colourless oil. Rf = 0.69 (1:9, MeOH/EtOAc). IR (neat, νmax/cm
-1): 3310, 
2944, 1779, 1696, 1450, 1410, 1247, 1066, 1030, 740. 1H NMR (500 
MHz, CDCl3) δ = 7.28 (d, J = 8.5 Hz, 2H, ArH), 6.90 (d, J = 8.5 Hz, 2H, 
ArH), 5.82 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, H4'), 5.04 (d, J = 17.0, 1H, 
H5'), 4.98 (d, J = 10.0 Hz, 1H, H5'), 4.52 (s, 2H, OCH2Ar), 4.17 (s, 2H, 
H8), 3.82 (s, 3H, OMe), 3.74-3.64 (m, 2H, H1), 3.48 – 3.43 (m, 1H, H4), 
3.15 (d, J = 9.0 Hz, 1H, H5), 2.90 (dt, J = 11.5, 7.0 Hz, 1H, H1'), 2.63 (dt, 
J = 11.5, 7.0 Hz, 1H, H1'), 2.14 (q, J = 7.0 Hz, 2H, H3'), 2.04 – 1.95 (m, 
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1H, H3), 1.83 – 1.74 (m, 2H, H2), 1.63-1.59 (m, 2H, H2'), 1.58 – 1.48 (m, 
1H, H3) ppm. 13C NMR (125 MHz, CDCl3) δ = 159.8 (ArC), 138.5 (C4'), 
130.1 (ArCH), 129.7 (ArC), 115.3 (C5'), 114.2 (ArCH), 85.2 (C6), 81.7 
(C7), 73.0 (C4), 71.6 (OCH2Ar), 63.2 (C1), 57.4 (C8), 56.0 (C5), 55.6 
(OMe), 46.9 (C1'), 31.7 (C3'), 31.1 (C3), 29.7 (C2), 29.6 (C2') ppm. 
ESIMS m/z 362 [(M+H)+ 100%]. HRESIMS calcd. for C21H32O4N: (M+H)
+ 
362.2321; found: 362.2331. 
(9H)-Fluoren-9-yl)methyl (4R*,5R*)-5,8-dihydroxy-1-(4-
methoxybenzyloxy)oct-2-yn-4-yl(pent-4-enyl)carbamate (22): To a 
solution of the amine 21 (975 mg, 2.7 mmol) in THF (40 mL), was added 
a saturated solution of Na2CO3 (20 mL) and the mixture was allowed to 
cool to 0 0C. FmocCl (768 mg. 2.97 mmol) was added portionwise at 0 0C 
and the reaction mixture was stirred at rt for 4 h. The organic phase was 
removed in vacuo and the aqueous layer was extracted with EtOAc (3 x 
50 mL). The organic extracts were combined, dried over MgSO4 and 
filtered. The solvent was removed in vacuo and the residue was purified 
by column chromatography (3:2, EtOAc/petroleum spirit) to give the 
Fmoc-diol 22 (1.511 g, 96% yield) as a waxy solid. Rf = 0.60 (9:1, 
EtOAc/petroleum spirit). IR (neat, νmax/cm
-1): 3436, 2927, 1687, 1611, 
1458, 1248, 1066, 1032, 739. 1H NMR (500 MHz, CDCl3, rotamers 
evident) δ = 7.76 (J = 8.5 Hz, 2H, ArH), 7.59 (J = 8.5 Hz, 2H, ArH), 7.39 
(t, J = 8.5 Hz, 2H, ArH), 7.31 (t, J = 8.5 Hz, 2H, ArH), 7.23 (J = 9.0 Hz, 
2H, ArH), 6.87 (J = 9.0 Hz, 2H, ArH), 5.72-5.62 (bm, 1H, H4''), 5.01-4.90 
(bm, 2H, H5''), 4.77-4.72 (bm, 1H, FmocCH2O), 4.67-4.57 (bm, 2H, 
FmocCH2O and H1'), 4.47 (s, 2H, OCH2Ar), 4.23 (t, J = 6.0 Hz. 1H, 
FmocCH), 4.12 (s, 2H, H4'), 3.80 (s, 3H, OMe), 3.67-3.58 (bm, 3H, H1 
and H4), 3.12-2.97 (bm, 2H, H1'), 1.90-1.80 (bm, 2H, H3'), 1.75-1.65 (bm, 
2H, H2'), 1.55-1.40 (bm, 4H, H2 and H3) ppm. 13C NMR (125 MHz, 
CDCl3 rotamers evident) δ = 159.7 (Ar), 144.1 (Ar), 141.6 (Ar), 138.0 
(C4'), 129.9 (Ar), 129.5 (Ar), 127.9 (Ar), 127.3 (Ar), 124.9 (Ar), 120.2 (Ar), 
115.2 (C5''), 114.1 (Ar), 82.5 (C7), 82.2 (C6), 73.0 (b, C4), 71.5 (OCH2Ar), 
67.2 (FmocCH2O), 63.0 (C1), 57.2 (C8), 55.5 (OMe), 54.9 (b,C5), 47.7 
(FmocCH), 45.6 (b, C1''), 31.4 (C3'), 31.2 (C2'), 29.4 (C3), 28.8 (b, C2) 
ppm. ESIMS m/z 606 [(M+Na)+ 100%]. HRESIMS calcd. for 
C36H41O6NNa: (M+Na)
+ 606.2832; found: 606.2822. 
(9H)-Fluoren-9-yl)methyl (R*)-4-(4-methoxybenzyloxy)-1-((R*)-5-
oxotetrahydrofuran-2-yl)but-2-ynyl(pent-4-enyl)carbamate (23): To a 
solution of the diol 22 (1.28 g, 2.2 mmol) in anhydrous CH2Cl2 (30 mL) 
were added TEMPO (69 mg, 0.44 mmol) and BAIB (2.83 g, 8.8 mmol) at 
rt and the mixture was stirred at rt for 18 h. The reaction was quenched 
by 0.1 N Na2S2O3 solution (20 mL). The organic phase was separated 
and the aqueous phase was extracted with CH2Cl2 (3 x 50 mL). The 
organic extracts were combined, dried over MgSO4 and filtered. The 
solvent was evaporated in vacuo and the residue was purified by column 
chromatography (3:2, EtOAc/petroleum spirit) to give the Fmoc-lactone 
23 (813 mg, 84% yield) as a waxy solid. Rf = 0.65 (3:2, EtOAc/petroleum 
spirit). IR (neat, νmax/cm
-1): 3346, 2935, 1773, 1612, 1513, 1455, 1451, 
1246, 1713, 1067, 1029, 919, 817. 1H NMR (500 MHz, CDCl3, rotamers 
evident) δ = 7.79 (d, J = 7.5 Hz, 2H, ArH), 7.63 (t, J = 7.0 Hz, 2H, ArH), 
7.43 (t, J = 7.5 Hz, 2H, ArH), 7.35 (t, J = 7.0 Hz, 2H, ArH), 7.27 (d, J = 
8.5 Hz, 2H, ArH), 6.91 (d, J = 8.5 Hz, 2H, ArH), 5.72-5.3 (bm, 1H, H4''), 
5.15-5.05 (bm, 3H, H5'' and H1'), 4.71-4.63 (bm, 2H, H5 and FmocCH2O), 
4.62-4.57 (bm, 1H, FmocCH2O), 4.50 (bs, 2H, OCH2Ar), 4.27 (t, J = 5.0 
Hz, 1H, FmocCH), 4.16 (bs, 2H, H4'), 3.84 (s, 3H, OMe), 3.34-3.26 (bm, 
1H, H1'), 3.13-3.07 (bm, 1H, H1''), 2.59-2.52 (bm, 1H, H3), 2.12-2.03 (bm, 
3H, H3 and 2H3"), 1.89-1.83 (bm, 1H, H4), 1.58-1.52 (bm, 1H, H2"), 
1.45-1.38 (bm, 1H, H2") ppm. 13C NMR (126 MHz, CDCl3, rotamers 
evident) δ = 176.2 (C2), 159.5 (Ar), 156.3 (b, FmocCO), 143.8 (Ar), 141.4 
(Ar), 137.7 (C4''), 129.7 (Ar), 129.1 (Ar), 127.4 (Ar), 127.1 (Ar), 124.7 (Ar), 
120.0 (Ar), 115.1 (b, C3''), 113.9 (Ar), 83.2 (C3'), 79.4 (b, C5), 78.8 (b, 
C2'), 71.4 (OCH2Ar), 67.1 (b, FmocCH2O), 56.8 (C4'), 55.3 (OMe), 52.4 
(b, C1'), 47.3 (FmocCH), 31.1 (C3"), 28.2 (C2"), 28.1 (b,C3), 24.9 (C4) 
ppm. ESIMS m/z 602 [(M+Na)+ 100%]. HRESIMS calcd. for 
C36H37O6NNa: (M+Na)
+ 602.25143; found: 602.2519. 
(R*)-5-((R*)-4-(4-Methoxybenzyloxy)-1-(pent-4-enylamino)but-2-
ynyl)dihydrofuran-2(3H)-one (24): Triethyamine (5 mL) was added to a 
solution of the Fmoc-lactone 23 (2.432 g, 4.2 mmol) in CH3CN (20 mL) at 
rt and the mixture was allowed to stir at rt for 14 h. The solvent was 
evaporated in vacuo and the residue was purified by column 
chromatography (4:1, EtOAc/petroleum spirit) to give the lactone 24 
(1.289 g, 86% yield) as a pale yellow oil. Rf = 0.63 (9:1, EtOAc/petroleum 
spirit). IR (neat, νmax/cm
-1): 3343, 2935, 2841, 1773, 1611, 1512, 1247, 
1067, 1029, 816. 1H NMR (500 MHz, CDCl3) δ = 7.28 (d, J = 8.5 Hz, 2H, 
ArH), 6.89 (d, J = 8.5 Hz, 2H ArH),  5.82 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, 
H4''), 5.03 (d, J = 17.0 Hz, 1H, H5''), 4.97 (d, J = 10.0 Hz, 1H, H5'')), 4.60 
(dd, J = 7.0, 5.5 Hz, 1H, H5), 4.52 (s, 2H, OCH2Ar), 4.17 (s, 2H, H4'), 
3.81 (s, 3H, OMe), 3.59 (d, J = 5.5 Hz, 1H, H1'), 2.92 (dt, J = 11.5, 7.0 Hz, 
1H, H1''), 2.67 – 2.59 (m, 2H, H1'' and H3), 2.54 (m, 1H, H3), 2.39 – 2.31 
(m, 1H, H4), 2.27 – 2.19 (m, 1H, H4), 2.12 (q, J = 7.0 Hz, 2H, H3''), 1.64 
– 1.55 (m, 2H, H2'') ppm. 13C NMR (125 MHz, CDCl3) δ = 177.1 (C1), 
159.7 (ArC), 138.5 (C4''), 130.0 (ArCH), 129.6 (ArC), 115.1 (C5''), 114.2 
(ArCH), 83.7 (C2'), 81.7 (C3'), 81.4 (C5), 71.6 (OCH2Ar), 57.3 (C4'), 55.6 
(OMe), 54.7 (C1'), 47.6 (C1''), 31.7 (C3''), 29.4 (C2''), 28.7 (C3), 24.5 
(C4) ppm. ESIMS m/z 380 [(M+Na)+ 100%]. HRESIMS calcd. for 
C21H27O4NSiNa: (M+Na)
+ 380.1838; found: 380.1842. 
(5R*,6R*)-5-Hydroxy-6-(3-(4-methoxybenzyloxy)prop-1-ynyl)-1-(pent-
4-enyl)piperidin-2-one (25): To solution of the amino-lactone 24 (1.086 
g, 3.3 mmol) in MeOH (12 mL) was added Et3N (3 mL) and the mixture 
was stirred at reflux temperature for 3 d. The solvent was evaporated in 
vacuo and the residue was purified by column chromatography (9:1, 
EtOAc/petroleum spirit) to afford the lactam 25 (920 mg, 84% yield) as a 
pale yellow oil. Rf = 0.63 (1:9, MeOH/EtOAc). IR (neat, νmax/cm
-1): 3361, 
2930, 1614, 1513, 1438, 1413, 1247, 1067, 1031, 817. 1H NMR (500 
MHz, CDCl3) δ = 7.24 (d, J = 7.5 Hz, 2H, ArH), 6.87 (d, J = 7.5 Hz, 2H, 
ArH), 5.79 (ddt, J = 17.0, 10.0, 4.5 Hz, 1H, H4''), 5.01 (d, J = 17.0 Hz, 1H, 
H5''), 4.95 (d, J = 10.0 Hz, 1H, H5''), 4.49 (s, 2H, OCH2Ar), 4.32 (s, 1H, 
H6), 4.17 (s, 2H, H3'), 4.01 – 3.95 (m, 1H, H5), 3.79 (s, 3H, OMe), 3.81 – 
3.71 (m, 1H, H1''), 3.12 (dt, J = 14.0, 7.0 Hz 1H, H1''), 2.59-2.53 (m, 1H, 
H3), 2.38 (dt, J = 11.5, 7.0 Hz, 1H, H3), 2.14 – 2.02 (m, 3H, H4 and H3''), 
1.95-1.88 (m, 1H, H4), 1.76 – 1.62 (m, 2H, H2'') ppm. 13C NMR (125 MHz, 
CDCl3) δ = 169.0 (C1), 159.8 (ArC), 138.0 (C4''), 130.2 (ArCH), 129.3 
(ArC), 115.4 (C5''), 114.2 (ArCH), 83.2 (C2'), 81.8 (C1'), 71.9 (OCH2Ar), 
66.8 (C5), 57.3 (C3'), 55.6 (OMe), 55.2 (C6) 46.2 (C1''),  31.4 (C3''), 29.8 
(C3), 27.1 (C4), 26.7 (C2'') ppm. ESIMS m/z 380 [(M+Na)+ 100%]. 
HRESIMS calcd. for C21H27O4NSiNa: (M+Na)
+ 380.1838; found: 
380.1839. 
(5R*,6R*)-5-(tert-Butyldimethylsilyloxy)-6-(3-(4-
methoxybenzyloxy)prop-1-ynyl)-1-(pent-4-enyl)piperidin-2-one (26): 
To a solution of the alcohol 25 (990 mg, 2.77 mmol) in CH2Cl2 (30 mL) 
were added TBSOTf (10.43 mL, 1.85 mmol) and 2,6-lutidine (0.32 mL, 
2.77 mmol) at 0 0C. The mixture was warmed to rt and stirred for 1 h. 
This step was repeated three times and the reaction mixture was stirred 
at rt for 12 h. The solvent was evaporated in vacuo and the residue was 
purified by column chromatography (3:2, EtOAc/petroleum spirit) to give 
compound 26 (1.16 g, 81% yield) as a colourless oil. Rf = 0.62 (9:1, 
EtOAc/petroleum spirit). IR (neat, νmax/cm
-1): 2936, 1742, 1635, 1610, 
1462, 1231, 1170, 1032. 1H NMR (500 MHz, CDCl3) δ = 7.29 (d, J = 8.5 
Hz, 2H, ArH), 6.90 (d, J = 8.5 Hz, 2H, ArH), 5.84 (ddt, J = 17.0, 10.0, 6.5 
Hz, 1H, H4''), 5.06 (d, J = 17.0 Hz, 1H, H5''), 5.00 (d, J = 10.0 Hz, 1H, 
H5''), 4.55 (s, 2H, OCH2Ar), 4.23 (d, J = 3.0 Hz, 1H, H6), 4.20 (s, 2H, H3'), 
4.08 – 4.03 (m, 1H, H5), 3.83 (s, 3H, OMe), 3.79 (dt, J = 14.0, 7.0 Hz, 1H, 
H1''), 3.18 (dt, J = 14.0, 7.0 Hz, 1H, H1''), 2.64-2.58 (ddd, J = 18.0, 7.0, 
3.5 Hz, 1H, H3), 2.61 (ddd, J = 18.0, 10.0, 7.0 Hz, 1H, H3), 2.25 – 2.15 
(m, 1H, H4), 2.10 (q, J = 7.0 Hz, 2H, H3''), 1.89 – 1.83 (m, 1H, H4), 1.72 
(quin, J = 7.5 Hz, 2H, H2''), 0.94 (s, 9H, (CH3)3C)), 0.15 (s, 6H, (CH3)2Si)) 
ppm. 13C NMR (125 MHz, CDCl3) δ = 169.0 (C2), 159.7 (ArC), 138.2 
(C4''), 130.0 (ArCH), 129.7 (ArC), 115.3 (C5''), 114.2 (ArCH), 82.8 (C2'), 
81.6 (C1'), 71.3 (OCH2Ar), 68.2 (C5), 57.2 (C3'), 55.6 (OMe), 55,5 (C6), 
46.1 (C1''), 31.4 (C3''), 29.7 (C3), 27.5 (C4), 27.0 (C2''), 26.0 ((CH3)3C), 
18.4 ((CH3)3C), -4.2 (CH3Si) ppm. ESIMS m/z 494 [(M+Na)
+ 100%]. 
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HRESIMS calcd. for C27H41O4NSiNa: (M+Na)
+ 494.2708; found: 
494.2703. 
(5R*,6R*)-5-(tert-Butyldimethylsilyloxy)-6-(3-hydroxyprop-1-ynyl)-1-
(pent-4-enyl)piperidin-2-one (27): To a mixture of the PMB ether 26 
(1.178 g, 2.5 mmol) in CH2Cl2 (50 mL) and water (5 mL,) was added 
DDQ (1.022 g, 4.5 mmol) portionwise at 0 0C and the mixture was 
allowed to stirred at rt for 18 h. Then the mixture was diluted with CH2Cl2 
(100 mL) and washed with water (2 x 50 mL). The organic layer was 
dried over MgSO4 and filtered. The solvent was evaporated in vacuo and 
the residue was purified by column chromatography (4:1, 
EtOAc/petroleum spirit) to give the primary alcohol 27 (694 mg, 79% 
yield) as a yellow oil. Rf = 0.57 (9:1, EtOAc/petroleum spirit). IR (neat, 
νmax/cm
-1): 3326, 2926, 2869, 2361, 1622, 1454, 1126, 1024, 913. 1H 
NMR (500 MHz, CDCl3) δ 5.81 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H, H4''), 
5.03 (d, J = 17.0 Hz, 1H, H5''), 4.98 (d, J = 10.0 Hz, 1H, H5'), 4.34 (s, 1H, 
H6), 4.31 (s, 2H, H3'), 4.05-4.00 (m, 1H, H5), 3.77 (dt, J = 13.5, 8.0 Hz, 
1H, H1''), 3.16 (dt, J = 13.5, 8.0 Hz, 1H, H1''), 2.59 (ddd, dt, J = 18.0, 6.5, 
4.0 Hz 1H, H3), 2.40 (dt, J = 17.5, 7.5 Hz 1H, H3), 2.20-2.13 (m, H, H4), 
2.12-2.08 (m, 1H, H3'), 1.98-1.91 (m,1H, H4), 1.67 (quin, J = 7.5 Hz, 2H, 
H2''), 0.86 (s, 9H, (CH3)3C), 0.10 (s, 6H, (CH3)2Si). 
13C NMR (126 MHz, 
CDCl3) δ 169.0 (C2), 137.8 (C4''), 111.1 (C5''), 82.5 (C2'), 81.4 (C1'), 
68.7 (C5), 57.3 (C6), 55.9 (C3'), 45.9 (C1''), 31.0 (C3), 29.7 (C3’’), 27.3 
(C2''), 26.5 (C4), 26.1 ((CH3)3C), 18.5 ((CH3)3C), -4.7 (CH3Si). ESIMS 
m/z 374 [(M+Na)+ 100%]. HRESIMS calcd. for C19H33O3NSiNa, (M+Na)
+ 
374.2127, found:374.2123. 
Methyl 3-((2R*,3R*)-3-(tert-butyldimethylsilyloxy)-6-oxo-1-(pent-4-
enyl)piperidin-2-yl)propiolate (5): To a solution of the primary alcohol 
27 (635 mg, 1.81 mmol) in acetone (20 mL) was added Jones’ reagent 
(2.7 mL) dropwise at 0 0C. After stirring for 30 min at 0 0C, CH3OH (0.5 
mL) was added and the reaction mixture was stirred for additional 10 min 
at 0 0C. Water (40 mL) was added and the mixture then was extracted 
with CH2Cl2 (4 x 60 mL). The organic extracts were combined, dried over 
MgSO4 and filtered. The solvent was evaporated in vacuo to give the 
crude acid (594 mg, 90% yield) as a yellow solid, which was used in the 
next step without further purification. To a solution of this acid (594 mg, 
1.63 mmol) in anhydrous DMF (20 mL), was added K2CO3 (450 mg, 3.26 
mmol) at rt and the mixture was stirred for 15 min under a N2 atmosphere. 
Then MeI (610 μL, 9.8 mmol) was added and the reaction mixture was 
allowed to stirred at rt for 14 h. Water (40 mL) was added and the mixture 
was extracted with CH2Cl2 (3 x 60 mL). The organic extracts were 
combined, dried over MgSO4 and filtered. The solvent was evaporated in 
vacuo and the residue was purified by column chromatography (2:3, 
EtOAc/petroleum spirit) to give the ester 5 (413 mg, 67% yield) as a pale 
yellow oil. NMR analysis indicated approximately 90% purity. Rf = 0.65 
(4:1, EtOAc/petroleum spirit). IR (neat, νmax/cm
-1): 2930, 1717, 1635, 
1436, 1249, 858, 751. NMR (500 MHz, CDCl3) δ = 5.82 (ddt, J = 17.5, 
10.5, 6.0 Hz, 1H, H4''), 5.04 (d, J = 17.5 Hz, 1H, H5''), 4.98 (d, J = 10.0 
Hz, 1H, H5'), 4.27 (d, J = 3.5 Hz, 1H, H2), 4.10-4.05 (m, 1H, H3), 3.78 (s, 
3H, OMe), 3.74 (dt, J = 13.5, 8.0 Hz, 1H, H1''), 3.15 (dt, J = 13.5, 7.5 Hz, 
1H, H1''), 2.63-2.57 (ddd, dt, J = 18.0, 7.0, 6.5, Hz 1H, H5), 2.38 (ddd, J 
= 18.0, 10.0, 7.0 Hz 1H, H5), 2.16-2.10 (m, 1H, H4), 2.07 (quin, J = 6.5 
Hz, 2H, H3''), 1.91-1.85 (m, 1H , H4), 1.72-1.65 (m , 2H, H2''), 0.91 (s, 9H, 
(CH3)3C), 0.12 (s, 6H, (CH3)2Si) ppm.
 13C NMR (125 MHz, CDCl3) δ = 
168.8 (C6), 153.8 (C3'), 138.0 (C4''), 115.5 (C5''), 84.0 (C1'), 77.2 (C2'), 
67.8 (C3), 55.7 (C5), 53.1 (OMe), 46.4 (C1''), 31.4 (C3''), 29.5 (C5), 27.7 
(C4),26.8 (C2''), 25.9 ((CH3)3C), 18.3 ((CH3)3C), -4.2 (CH3Si) ppm. 
ESIMS m/z 402 [(M+Na)+ 100%]. HRESIMS calcd. for C20H33O4NSiNa: 
(M+Na)+ 402.2084; found: 402.2077. 
Methyl 2-((1R*,10aR*)-1-(tert-butyldimethylsilyloxy)-4-oxo-
1,2,3,4,6,7,8,10a-octahydropyrido[1,2-a]azepin-10-yl)acrylate (28): To 
a solution of the ene-yne 5 (872 mg, 2.3 mmol) in anhydrous CH2Cl2 (80 
mL) was added Grubb’s 1st generation Ru catalyst (189 mg, 0.23 mmol) 
under a N2 atmosphere and the mixture was stirred at rt for 8 h. The 
reaction mixture then was exposed to open air for 30 min. The solvent 
was evaporated in vacuo and the residue was purified by column 
chromatography (3:2, EtOAc/petroleum spirit) to give the bicyclic 
compound 28 (680 mg, 78% yield) as a yellow oil. Rf = 0.69 (4:1, 
EtOAc/petroleum spirit). IR (neat, νmax/cm
-1): 2952, 2929, 1720, 1639, 
1251, 1222, 1202, 1074, 990, 812, 774. 1H NMR (500 MHz, CDCl3) δ = 
6.12 (s, 1H, H4'), 5.94 – 5.87 (t, J = 8.0 Hz, 1H, H9), 5.73 (s, 1H, H4'), 
4.27 (s, 1H, H10a), 4.23 (dd, J = 13.0, 7.5 Hz,  1H, H6),  4.00 (s, 1H, H1), 
3.77 (s, 3H, OMe), 3.20 (td, J = 13.0, 6.5 Hz, 1H, H6), 2.75 – 2.64 (m, 2H, 
H3 and H8), 2.34 (dd, J = 17.7, 5.7 Hz, 1H, H3), 2.23 – 2.13 (m, 1H, H7), 
1.96 – 1.90 (m, 1H, H2), 1.90 – 1.76 (m, 2H, H8 and H2), 1.58 – 1.49 (m, 
1H, H7), 0.88 (s, 9H, (CH3)3C), 0.02 (s, 6H, (CH3)2Si) ppm. 
13C NMR 
(126 MHz, CDCl3) δ = 169.5 (C4), 167.5 (C2'), 142.3 (C10), 136.1 (C1'), 
132.8 (C9), 127.4 (C4'), 67.6 (C10a), 66.5 (C1), 52.5 (OMe), 42.3 (C6), 
28.1 (C2), 27.1 (C3), 26.2 ((CH3)3C), 24.0 (C7), 22.1 (C8), 18.5 ((CH3)3C), 
-4.7 (CH3Si) ppm. ESIMS m/z 380 [(M+H)
+ 100%]. HRESIMS calcd. for 
C20H34O4NSi: (M+H)
+ 380.2261; found: 380.2257. 
Methyl 2-((1R*,10aR*)-1-(tert-butyldimethylsilyloxy)-4-oxo-
1,2,3,4,6,7,8,10a-octahydropyrido[1,2-a]azepin-10-yl)propanoate (4): 
Sodium borohydride (532 mg, 14 mmol) was added portionwise to a 
solution of the enone 28 (663 mg, 1.75 mmol) in anhydrous MeOH (20 
mL) at 0 0C under a N2 atmosphere and the mixture was stirred at 0 
0C 
for 3 h. Saturated aqueous NaHCO3 solution (30 mL) was added at 0 
0C 
and the mixture was extracted with EtOAc (3 x 50 mL). The combined 
organic extract was dried over MgSO4 and filtered. The solvent was 
removed in vacuo and the residue was purified by column 
chromatography (3:2, EtOAc/petroleum spirit) to give an inseparable 
mixture of diastereomers 4 (517 mg, 78% yield) as a pale yellow oil. Rf = 
0.69 (4:1, EtOAc/petroleum spirit). IR (neat, νmax/cm
-1): 2948, 2930, 1736, 
1631, 1462, 1251, 1202, 1166, 1095, 993, 836. 1H NMR (500 MHz, 
CDCl3) major diastereomer δ = 5.86-5.79 (m, 1H, H9), 4.26-4.19 (m, H1 
and H6), 3.93 (s, 1H, H10a), 3.69 (s, 3H, OMe), 3.04-2.96 (m, 1H, H1'), 
2.85-2.69 (m, 2H, H6 and H3), 2.69-2.56 (m, 1H, H8), 2.41-2.32 (m, 1H, 
H3), 2.16-2.07 (m, 1H, H7), 2.02-1.94 (m, 1H, H2), 1.91-1.83 (m, 1H, H2), 
1.83-1.75 (m, 1H, H8), 1.34 (d, J = 7.5 Hz, 3H, H4'), 0.86 (s, 9H, 
(CH3)3C), 0.11 (s, 6H, (CH3)2Si) ppm.
 13C NMR (125 MHz, CDCl3) δ = 
174.5 (C2’), 169.5 (C4), 135.9 (C10), 127.8 (C9), 69.2 (C1), 66.9 (C10a), 
52.1 (OMe), 44.8 (C1'), 42.1 (C6), 28.4 (C2), 27.1 (C3), 26.1 ((CH3)3C), 
23.9 (C7), 21.5 (C8), 19.0 (C4'), 18.5 ((CH3)3C), -4.7 (CH3Si) ppm.
 1H 
NMR (500 MHz, CDCl3) minor diastereomer (in part) δ = 5.86-5.79 (m, 
1H, H9), 4.19-4.13 (m, H1 and H6), 3.97 (s, 1H, H10a), 3.70 (s, 3H, 
OMe), 3.04-2.96 (m, 1H, H1'), 2.94-2.86 (m, 1H, H6), 2.85-2.69 (m, 1H, 
H3), 2.69-2.56 (m, 1H, H8), 2.41-2.32 (m, 1H, H3), 2.16-2.07 (m, 1H, H7), 
2.02-1.94 (m, 1H, H2), 1.91-1.83 (m, 1H, H2), 1.83-1.75 (m, 1H, H8), 
1.35 (d, J = 7.5 Hz, 3H, H4'), 0.86 (s, 9H, (CH3)3C), 0.1 (s, 6H, (CH3)2Si) 
ppm. 13C NMR (125 MHz, CDCl3) δ = 174.4 (C2’), 169.5 (C4),134.7 (C10), 
127.5 (C9), 69.8 (C1), 65.8 (C10a), 52.4 (OMe), 43.2 (C1'), 42.1 (C6), 
28.2 (C2), 27.0 (C3), 26.1 ((CH3)3C), 23.8 (C7), 21.5 (C8), 19.0 (C4'), 
18.5 ((CH3)3C), -4.7 (CH3Si) ppm. ESIMS m/z 382 [(M+H)
+ 100%]. 
HRESIMS calcd. for C20H36NO4Si: (M+H)
+ 382.2414; found: 382.2411. 
Bromolactonization of 4: To a solution of 4 (648 mg, 1.3 mmol) in 
MeOH (15 mL), was added slowly 1M aqueous NaOH solution (13.7 mL) 
at 0 0C and the mixture was stirred at 0 0C for 8 h. The mixture was 
acidified to pH = 5 with 1M HCl solution and extracted with EtOAc (4 x 50 
mL). The organic extracts were combined, dried over MgSO4 and filtered. 
The solvent was evaporated in vacuo to afford a diasteromeric mixture of 
acids, which was used in the step without further purification. To a 
solution of this acid in CH3CN (4 mL) was added diphenyl diselenide (21 
mg, 0.65 mmol) and the resulting mixture was cooled to -30 0C. N-
bromosuccinimide (277 mg, 1.69 mmol) was added with stirring, and the 
resulting reaction mixture was stirred at -30 0C for 3 h. The resulting 
solution was concentrated to <1 mL in vacuo, and EtOAc (60 mL) was 
added. The resulting organic layer was washed with water (2 x 10 mL), 
dried over MgSO4 and filtered. The solvent was evaporated in vacuo to 
afford a yellow residue, which then was dissolved in EtOAc (10 mL). Et3N 
(0.2 mL) was added and the solution was stirred at rt for 18 h.13 The 
solution was then diluted with EtOAc (40 mL), washed with water (2 x 10 
mL), dried over MgSO4 and filtered.  Purification by column 
chromatography (6:4 to 9:1, EtOAc/petroleum spirit) of the resulting 
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residue gave the tricyclic compounds 29 (192 mg, 31% yield) and 30 
(124 mg, 20% yield) as white solids. 
(3aR*,11R*,11aR*)-11-(tert-Butyldimethylsilyloxy)-1,3a,11a-trimethyl-
3a,4,5,6,9,10,11,11a-octahydrofuro[3,2-c]pyrido[1,2-a]azepine-2,8-
dione (29): NMR analysis indicated approximately 90% purity. Mp = 137-
139 ºC. Rf = 0.69 (4:1, EtOAc/petroleum spirit). IR (neat, νmax/cm
-1): 2951, 
2930, 1751, 1630, 1253, 1196, 1148, 1082, 993, 835, 776. 1H NMR (500 
MHz, CDCl3) δ = 4.97 (d, J = 9.5 Hz, 1H, H3a), 4.71 (s, 1H, H11a), 4.52 
(d, J = 10.5 Hz, 1H, H6), 4.21 (s, 1H, H11), 2.79 – 2.69 (m, 1H, H9), 2.54 
– 2.47 (m, 1H, H4), 2.42-2.36 (m, 1H, H9), 2.27 – 2.15 (m, 1H, H6), 2.02-
1.96 (m, 2H, H10), 1.90 (s, 3H, CH3), 1.88-1.81 (m, 1H, H5), 1.75-1.65 
(m, 1H, H5), 1.22 – 1.14 (m, 1H, H4), 0.84 (s, 9H, (CH3)3C), 0.03 (s, 6H, 
(CH3)2 Si) ppm. 
13C NMR (125 MHz, CDCl3) δ = 173.5 (C2), 169.9 (C8), 
163.6 (C11b), 124.2 (C1), 83.9 (C3a) , 67.7 (C11), 63.2 (C11a), 47.6 
(C6), 36.5 (C4) , 28.4 (C10), 26.6 (C9), 26.0 ((CH3)3C), 25.1 (C5), 18.2 
((CH3)3C), 9.74 (C1’), -4.6 (CH3Si), -4.9 (CH3Si) ppm. ESIMS m/z 366 
[(M+H)+ 100%]. HRESIMS calcd. for C19H32NO4Si: (M+H)
+ 366.2101; 
found: 366.2099. 
(3aS*,11R*,11aR*)-11-(tert-Butyldimethylsilyloxy)-1-methyl-
3a,4,5,6,9,10,11,11a-octahydrofuro[3,2-c]pyrido[1,2-a]azepine-2,8-
dione (30): NMR analysis indicated approximately 90% purity. Mp = 140-
142 ºC. Rf = 0.69 (4:1, EtOAc/petroleum spirit). IR (neat, νmax/cm
-1): 2954, 
2930, 1749, 1628, 1254, 1160, 1103, 938, 834, 777. 1H NMR (500 MHz, 
CDCl3) δ = 4.80 (d, J = 11.0 Hz, 1H, H3a), 4.51 – 4.45 (m, 1H, H11), 
4.37-4.30  (m, 1H, H6), 4.27 (d, J = 3.0 Hz, 1H, H11a), 2.94 – 2.87 (m, 
1H, H6), 2.57 (dt, J = 17.5, 7.0 Hz, 1H, H9), 2.44 (dt, J = 17.5, 7.0 Hz 1H, 
H9), 2.33 – 2.26 (m, 1H, H4), 2.19 – 2.07 (m, 3H, H10 and H5), 2.10 (s, 
3H, H1’), 1.74 – 1.63 (m, 1H, H5), 1.60-1.54 (m, 1H, H4), 0.86 (s, 9H, 
(CH3)3C), 0.12 (s, 3H, CH3Si), 0.07 (s, 3H, CH3Si) ppm. 
13C NMR (125 
MHz, CDCl3) δ = 174.5 (C2), 170.1 (C8), 157.3 (C11b), 123.3 (C1), 83.4 
(C3a), 68.3 (C11), 62.3 (C11a), 46.1 (C6), 29.3 (C9), 28.3 (C4), 27.9 
(C10), 26.0 ((CH3)3C), 21.5 (C5), 18.3 ((CH3)3C), 12.6 (C1’), -4.2 (CH3Si), 
-4.6 (CH3Si) ppm. ESIMS m/z 366 [(M+H)
+ 100%]. HRESIMS calcd. for 
C19H32NO4Si: (M+H)
+ 366.2101; found: 366.2110. 
Synthesis of 29 from 30: To a solution of compound 30 (104 mg, 0.28 
mmol) in CHCl3 (2 mL), was added DBU (3 drops) and the mixture was 
stirred at rt for 2 d. The solvent was evaporated in vacuo and the residue 
was purified by column chromatography (4:1, EtOAc/petroleum spirit) to 
give compound 29 (61 mg, 60% yield). 
 (1S*,3aR*,11R*,11aR*,11bR*)-11-(tert-Butyldimethylsilyloxy)-1-
methyldecahydrofuro[3,2-c]pyrido[1,2-a]azepine-2,8-dione (31): 
Magnesium turnings (39 mg, 1.64 mmol) were added to a solution of the 
α,β-unsaturated lactone 29 (40 mg, 0.11 mmol) in MeOH (1.2 mL) at 0 0C. 
The mixture was warmed to rt and stirred for 1 d. After cooling to 0 0C, 
acetic acid (12 µL, 0.22 mmol) was added and the resulting mixture was 
stirred at rt for 30 min. Water (5 mL) was added and the mixture was 
extracted with EtOAc (3 x 15 mL). The organic extracts were combined, 
dried over MgSO4 and filtered. The solvent was evaporated in vacuo and 
the residue was purified by column chromatography (7:3, 
EtOAc/petroleum spirit) to provide compound 31 (29 mg, 71% yield) as a 
white solid. Recrystalization for X-ray structural analysis was performed 
using a solvent mixture of CH2Cl2 and n-hexane at rt.
 Mp = 160-162 ºC Rf 
= 0.65 (9:1, EtOAc/petroleum spirit). IR (neat, νmax/cm
-1): 3233, 2957, 
2318, 1765, 1632, 1448, 1390, 1253, 1185, 1101, 1065, 1014, 774. 1H 
NMR (500 MHz, CDCl3) δ = 4.79 (td, J = 11.5, 2.5 Hz, IH, H3a), 4.48 (d, J 
= 13.5 Hz, IH, H6), 4.25 (s, 1H, H11), 3.73 (d, J = 7 Hz, 1H, H11a), 2.86 
(dq, J = 14.0, 7.0 Hz, 1H, H1), 2.71-2.60 (m, 2H, H6 and H9), 2.43-2.31 
(m , 3H, H9, H4 and H11b), 2.09-2.03 (m, 1H, H10), 1.92-1.84 (m, 2H, 
H10 and H5), 1.68-1.58 (m, 1H, H5), 1.43-1.33 (m, 1H, H4), 1.30 (d, J = 
7.0 Hz, 3H, H1'), 0.88 (s, 9H, (CH3)3C), 0.16 (s, 3H, CH3Si), 0.12 (s, 3H, 
CH3Si) ppm. 
13C NMR (125 MHz, CDCl3) δ = 177.9 (C2), 169.9 (C8), 
79.7 (C3a), 66.0 (C11), 59.3 (C11a), 53.4 (C11b), 43.1 (C6), 37.9 (C1), 
28.0 (C9), 26.8 (C10), 26.2 ((CH3)3C), 25.1 (C5), 18.3 ((CH3)3C), 15.2 
(C1'), -2.9 (CH3Si), -4.7 (CH3Si) ppm. ESIMS m/z 368 [(M+H)
+ 100%]. 
HRESIMS calcd. for C19H34O4NSi: (M+H)
+ 368.2257; found: 368.2256. 
(1S*,3aR*,11R*,11aR*,11b*R)-11-Hydroxy-1-
methyldecahydrofuro[3,2-c]pyrido[1,2-a]azepine-2,8-dione (3): To a 
solution of the TBS ether 31 (30 mg, 0.082 mmol) and acetic acid (12 μL, 
0.206 mmol, 3 equiv) at 0 ºC was added a solution of 1M TBAF in THF 
(206 µL, 0.206 mmol, 3 equiv). The mixture then was warmed to rt and 
stirred for 14 h. The reaction was quenched with saturated NaHCO3 
solution (5 mL) and extracted with EtOAc (3 x 15 mL). The organic 
extracts were combined, dried over MgSO4 and filtered. The solvent was 
evaporated in vacuo and the residue was purified by column 
chromatography (4:1, EtOAc/petroleum spirit) to give the alcohol 3 (16 
mg, 80% yield) as a pale yellow solid. Mp = 254-256 ºC. Rf = 0.68 (9:1, 
EtOAc/MeOH). IR (neat, νmax/cm
-1): 3340, 2957, 2856, 1765, 1624, 1183, 
1104, 1067, 1012, 870, 794. 1H NMR (500 MHz, CD3OD) δ = 4.86 – 4.78 
(m, 1H, H3a), 4.28 (d, J  =13.5 Hz, 1H, H6β), 4.22 (s, 1H, H11), 3.85 (dd, 
J  =7.5, 2.0 Hz 1H, H11a), 3.18 (dq, J = 14.0, 7.0 Hz, 1H, H1), 2.84 (t, J = 
13.5 Hz, 1H, H6α), 2.71 – 2.61 (m, 1H, H9), 2.61-2.54 (m, 1H, H10), 2.30 
(m, 1H, H9), 2.25-2.19 (m, 1H, H4), 2.01 – 1.88 (m, 1H, H10), 1.85-1.79 
(m, 1H, H5), 1.59 (m, 1H, H5), 1.46 (m, 1H, H4), 1.27 (d, J = 7.0 Hz, 3H, 
H1') ppm. 13C NMR (125 MHz, CD3OD) δ = 181.1 (C2), 172.9 (C8), 81.9 
(C3a), 64.6 (C11), 59.5 (C11a), 53.90 (C11b), 44.2 (C6), 39.1 (C1), 36.0 
(C4), 28.3 (C10), 27.7 (C9), 25.7 (C5), 15.0 (C1') ppm. ESIMS m/z 354 
[(M+H)+ 100%]. HRESIMS calcd. for C13H20O4N: (M+H)
+ 254.1392; 
found: 254.1396. 
Attempted synthesis of 2: To a solution of 3 (15.7 mg) in CH2Cl2 (3 mL) 
were added BIAB (24 mg, 0.07 mmol) and I2 (16.6 mg, 0.065 mmol). The 
mixture the was irradiated with a UV lamp at rt, 500 W for 30 min. The 
reaction was quenched with 1M Na2S2O3 (3 mL) and extracted with 
CH2Cl2 (3 x 10 mL). The organic extracts were combined, dried over 
MgSO4 and filtered. The solvent was evaporated in vacuo and the 
residue was purified by column chromatography (2:3, EtOAc/petroleum 
spirit) to give the major product 32 (3.4 mg, 16% yield) as a pale yellow 
oil and as a mixture of diastereomers (dr = 2.3:1).  Rf = 0.69 (4:1, 
EtOAc/petroleum spirit). IR (neat, νmax/cm
-1): 2924, 1764, 1640, 1501, 
1448, 1397, 1244, 973. 1H NMR (500 MHz, CDCl3) major isomer δ = 9.79 
(s, 1H, CHO), 7.06 (d, J = 9.0 Hz, 1H, H4), 4.24-4.13 (m, 2H, H8a and 
H6), 3.02-2.80 (m, 3H, H2', H6 and H3'), 2.80-2.62 (m, 3H, H3, H2' and 
H3'), 2.42-2.37 (m, 1H, H3a and H8), 2.11 (s, 3H, CH3CO), 180-1.75 (m, 
1H, H7), 1.68-1.56 (m, 2H, H8 and H7), 1.25 (d, J = 7.0 Hz, 3H, H3"). 13C 
NMR (125 MHz, CDCl3) major isomer δ = 200.9 (C4'), 177.0 (C2), 171.5 
(C1), 170.0 (CH3CO), 82.6 (C4), 78.1 (C8a), 55.2 (C3a), 41.0 (C6), 39.1 
(C2'), 34.4 (C8), 25.4 (C3'), 23.5 (C7), 21.0 (CH3CO), 14.7 (C3") ppm. 
1H 
NMR (500 MHz, CDCl3) minor isomer (in part) δ = 9.81 (s, 1H, CHO), 
6.66 (d, J = 8.0 Hz, 1H, H4), 4.13-4.07 (m, 2H, H8a and H6), 2.34-2.27 
(m, 1H, H3a), 2.03 (s, 3H, CH3CO), 1.21 (d, J = 7.0 Hz, 3H, H3") ppm. 
13C NMR (125 MHz, CDCl3) minor isomer δ = 200.6 (C4'), 177.4 (C2), 
171.8 (C1), 169.0 (CH3CO), 78.2 (C4), 77.3 (C8a), 54.0 (C3a), 41.0 (C6), 
38.5 (C2'), 34.0 (C8), 25.9 (C3'), 23.5 (C7), 20.8 (CH3CO), 15.0 (C3") 
ppm. ESIMS m/z 366 [(M+Na)+ 100%]. HRESIMS calcd. for 
C15H21O8NNa: (M+Na)
+ 366.1158; found: 366.1165. 
(1S*,3aR*,11R*,11aR*,11bR*)-11-(tert-Butyldimethylsilyloxy)-1-
methyl-8-thioxodecahydrofuro[3,2-c]pyrido[1,2-a]azepin-2(8H)-one 
(33): Lawessons’ reagent (21.2 mg, 0.053 mmol) was added to a solution 
of the lactam 31 (35 mg, 0.095 mmol) in THF (12 mL) and the reaction 
mixture was heated at reflux temperature for 3 h. The solvent was 
evaporated in vacuo and the residue was purified by column 
chromatography (3:1, EtOAc/petroleum spirit) to give the thiolactam 33 
(29 mg, 80% yield) as a white solid. Mp = 154-156 ºC. Rf = 0.61 (4:1, 
EtOAc/petroleum spirit). IR (neat, νmax/cm
-1): 2952, 1736, 1493, 1254, 
1177, 1154, 1066, 1010, 980, 794. 1H NMR (500 MHz, CDCl3) δ = 5.31 
(dd, J = 13.5, 4.0 Hz, 1H, H6β), 4.69 (dt, J = 11.5, 3.5 Hz, 1H, H3a), 4.34 
(s, 1H, H11), 3.76 (dd, J  = 7.5, 2.0 Hz 1H, H11a), 3.19-3.09 (m, 3H, H6 
and H9), 2.88 (dq, J = 14.0, 7.0 Hz, 1H, H1), 2.60 – 2.52 (m, 1H, H11b), 
2.40-2.33 (m, 1H, H4), 2.10 – 1.83 (m, 4H, H5 and H10), 1.47 (qd, J = 
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13.0, 5.5 Hz, 1H, H4), 1.31 (d, J = 7.0 Hz, 3H, H1'), 0.87 (s, 9H, (CH3)3C), 
0.15 (s, 3H, CH3Si), 0.11 (s, 3H, CH3Si) ppm.
 13C NMR (125 MHz, CDCl3) 
δ = 201.1 (C8), 177.4 (C2), 79.3 (C3a), 66.1 (C11), 62.2 (C11a), 52.9 
(C11b), 51.2 (C6), 38.0 (C1), 37.0 (C9), 35.4 (C4), 28.0 (C3), 26.2 
((CH3)3C), 23.1 (C5), 18.3 ((CH3)3C), 15.3 (C1'), -2.9 (CH3Si), -4.8 
(CH3Si) ppm.
 ESIMS m/z 384 [(M+H)+ 100%]. HRESIMS calcd. for 
C19H34O3NSiS: (M+H)
+ 384.2036; found: 384.2029. 
(1S*,3aR*,11R*,11aR*,11bR*)-11-(tert-Butyldimethylsilyloxy)-1-
methyldecahydrofuro[3,2-c]pyrido[1,2-a]azepin-2(8H)-one (34): An 
excess amount of Raney Ni (ca 20 mg) was added to a solution of the 
thiolactam 33 (26.5 mg, 0.07 mmol) in EtOH (4 mL) and the mixture was 
heated at reflux temperature for 4 h. The mixture was filtered through a 
small pad of celite and the filtered cake was washed with EtOH (60 mL). 
The solvent was evaporated in vacuo and the residue was purified by 
column chromatography (4:1, EtOAc/petroleum spirit) to give the amine 
34 (19 mg, 75% yield) as a pale yellow solid. Mp = 117-119 ºC. Rf = 0.58 
(4:1, EtOAc/petroleum spirit). IR (neat, νmax/cm
-1): 2946, 2927, 1762, 
1465, 1325, 1209, 1165, 1025. 1H NMR (500 MHz, CDCl3) δ = 5.01 (dt, J 
= 10.5, 3.0,  1H, H3a), 3.94 (s, 1H, H11), 2.88 (d, J = 11.1 Hz, 1H, H8), 
2.78 (dq, J = 14.0, 7.0 Hz, 1H, H1), 2.62 (dd, J = 19.0, 8.0 Hz, 1H, H6), 
2.48-2.40 (m, 2H, H6 and H8), 2.36 (d, J = 7.5 Hz, 1H, H11a), 2.28 (dd, J 
= 10.0, 5.0 Hz, 1H, H4), 2.19 (apparent dt, J = 12.0, 9.0 Hz, 1H, H11b), 
2.00 – 1.91 (m, 1H, H3), 1.91 – 1.83 (m, 1H, H3), 1.69 (dt, J = 16.0, 8.0 
Hz, 2H, H5), 1.41 – 1.33 (m, 2H, H9), 1.31 – 1.21 (m, 1H, H4), 1.30 (d,  J 
= 7.0 Hz, 3H, H1'), 0.89 (s, 9H, (CH3)3C), -0.11 (s, 6H (CH3)2Si,) ppm. 
13C NMR (125 MHz, CDCl3) δ = 179.3 (C2), 80.5 (C3a), 67.7 (C11), 63.7 
(C11a), 58.8 (C8), 55.0 (C6), 53.8 (C11b), 37.6 (C1), 36.1 (C4), 32.7 
(C10), 27.7 (C5), 26.3 ((CH3)3C), 21.5 (C9), 18.5 ((CH3)3C)  15.2 (C1'), -
3.0 (CH3Si), -4.6 (CH3Si) ppm. ESIMS m/z 354 [(M+H)
+ 100%]. 
HRESIMS calcd. for C19H36O3NSi: (M+H)
+ 354.24564; found: 354.2452. 
(1S*,3aR*,11R*,11aR*,11bR*)-11-Hydroxy-1-
methyldecahydrofuro[3,2-c]pyrido[1,2-a]azepin-2(8H)-one (35): To a 
solution of the TBS ether 34 (23 mg, 0.065 mmol) and acetic acid (11 μL, 
0.195 mmol) at 0 ºC was added a 1M solution of TBAF  in THF (195 μl, 
0.195 mmol). The mixture then was warmed to rt and stirred for 14 h. The 
reaction was quenched with saturated aqueous NaHCO3 solution (5 mL) 
and extracted with EtOAc (3 x 15 mL). The organic extracts were 
combined, dried over MgSO4 and filtered. The solvent was evaporated in 
vacuo and the residue was purified by column chromatography (4:1, 
EtOAc/petroleum spirit) to give the alcohol 35 (17 mg, 78% yield) as a 
pale yellow solid. NMR analysis indicated some impurities wee 
present. .Mp = 210-212 ºC. Rf = 0.61 (9:1, EtOAc/petroleum spirit). IR 
(neat, νmax/cm
-1): 3431, 2928, 1762, 1453, 1261, 1182, 1165, 1125, 1102, 
1075, 1025, 769, 682. 1H NMR (500 MHz, CDCl3) δ = 4.77 (dt, J = 11.0, 
3.5 Hz, 1H, H3a), 3.86 (s, 1H, H11), 2.96-2.84 (m, 2H, H1 and H8), 2.75 
– 2.68 (m, 1H, H6), 2.56 – 2.46 (m, 2H, H6 and H8), 2.46 – 2.42 (m, 1H, 
H11a), 2.31 (d, J = 10.0 Hz, 1H, H4), 2.20 (apparent ddd, J = 12.5, 11.0, 
8.0 Hz, 1H, H11b), 1.89 – 1.76 (m, 3H, H10, H9 and H5), 1.70 – 1.58 (m, 
1H, H5), 1.54 – 1.48 (m, 1H, H9), 1.43 – 1.32 (m, 1H, H10), 1.32 – 1.23 
(m, 1H, H4), 1.22 (d, J = 7.0 Hz, 3H, H1') ppm. 13C NMR (125 MHz, 
CDCl3) δ = 178.7 (C2), 80.6 (C3a), 65.7 (C11), 64.1 (C11a), 59.3 (C8), 
55.3 (C6), 53.4 (C11b), 37.7 (C1), 35.7 (C4), 32.0 (C10), 27.8 (C5), 21.2 
(C9), 14.4 (C1') ppm. ESIMS m/z 240 [(M+H)+ 100%]. HRESIMS calcd. 
for C13H22O3N: (M+H)
+ 240.1600; found: 240.1601. 
Attempted photochemical cyclization reaction of 35: To a solution of 
35 (14.4 mg, 0.06 mmol) in CH2Cl2 (2 mL) were added BIAB (24 mg, 0.07 
mmol) and I2 (16.6 mg, 0.065 mmol). The mixture the was irradiated with 
a UV lamp at rt, 500 W for 15 min. The reaction was quenched with 1M 
Na2S2O3 (3 mL) and extracted with CH2Cl2 (3 x 10 mL). The organic 
extracts were combined, dried over MgSO4 and filtered. The solvent was 
evaporated in vacuo. 1H NMR and TLC analysis analysis of the crude 
reaction mixture showed a complex mixture of products. 
CCDC 1419726 contains the supplementary crystallographic data for this 
paper. These data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.  
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Copies of the 1H and 13C NMR spectra of all new compounds.  
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